Abbott Laboratories
XMUN:ABL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
XMUN:ABL
|
US |
|
Chocoladefabriken Lindt & Spruengli AG
F:LSPP
|
CH |
|
A
|
Accenture PLC
XMUN:CSA
|
IE |
|
Schibsted ASA
OSE:SCHA
|
NO |
|
HAL Trust
F:HA4
|
MC |
|
B
|
Berkshire Hathaway Inc
F:BRH
|
US |
|
S
|
Singapore Telecommunications Ltd
DUS:SIT4
|
SG |
|
B
|
Boeing Co
XMUN:BCO
|
US |
|
A
|
Anglo American PLC
XMUN:NGLB
|
UK |
Wall St Price Targets
ABL Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABL is 103.46 EUR with a low forecast of 79.6 EUR and a high forecast of 122.34 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABL's stock price target?
Price Target
103.46
EUR
According to Wall Street analysts, the average 1-year price target for ABL is 103.46 EUR with a low forecast of 79.6 EUR and a high forecast of 122.34 EUR.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Abbott Laboratories?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 3 years is 20%.
What is the Pre-Tax Income forecast for Abbott Laboratories?
Projected CAGR
19%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 22%.
